Multipotent Islet-1 cardiovascular progenitors in development and disease

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 73, Issue , 2008, Pages 297-306

  Nakano, A ^a,b   Nakano, H ^a,b   Chien, K R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; NUCLEIC ACID BINDING PROTEIN; NUCLEIC ACID BINDING PROTEIN ISL1; UNCLASSIFIED DRUG; WNT PROTEIN; HOMEODOMAIN PROTEIN; INSULIN GENE ENHANCER BINDING PROTEIN ISL 1; INSULIN GENE ENHANCER BINDING PROTEIN ISL-1;

CELL FATE; CELL LINEAGE; CELL RENEWAL; CONFERENCE PAPER; CONGENITAL HEART DISEASE; CORONARY ARTERY; HEART CONDUCTION; HEART DEVELOPMENT; HEART OUTFLOW TRACT OBSTRUCTION; HUMAN; MESODERM; MUSCLE DEVELOPMENT; NONHUMAN; PACEMAKER; PRIORITY JOURNAL; PROGENY; STEM CELL; VALVE; CARDIAC STEM CELL; CARDIAC STEM CELL ISLET 1; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CORONARY ARTERY BLOOD FLOW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CONGENITAL HEART MALFORMATION; CYTOLOGY; FETUS HEART; GENETICS; METABOLISM; MOUSE; MULTIPOTENT STEM CELL; MYOBLAST; PATHOLOGY; PRENATAL DEVELOPMENT; REVIEW;

MAMMALIA;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; FETAL HEART; HEART DEFECTS, CONGENITAL; HOMEODOMAIN PROTEINS; HUMANS; MICE; MODELS, CARDIOVASCULAR; MULTIPOTENT STEM CELLS; MYOBLASTS, CARDIAC; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 68549104472     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2008.73.055     Document Type: Conference Paper

References (117)

1. Abu-Issa, R., Waldo, K., and Kirby, M.L. 2004. Heart fields: One, two or more? Dev. Biol. 272: 281-285.
2. Anderson, R.H., Brown, N.A., and Moorman, A.F. 2006. Development and structures of the venous pole of the heart. Dev. Dyn. 235: 2-9.
3. Aoki, Y., Niihori, T., Kawame, H., Kurosawa, K., Ohashi, H., Tanaka, Y., Filocamo, M., Kato, K., Suzuki, Y., Kure, S., et al. 2005. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat. Genet. 37: 1038-1040.
4. Bahuau, M., Flintoff, W., Assouline, B., Lyonnet, S., Le Merrer, M., Prieur, M., Guilloud-Bataille, M., Feingold, N., Munnich, A., Vidaud, M., et al. 1996. Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association. Am. J. Med. Genet. 66: 347-355.
5. Bahuau, M., Houdayer, C., Assouline, B., Blanchet-Bardon, C., Le Merrer, M., Lyonnet, S., Giraud, S., Recan, D., Lakhdar, H., Vidaud, M., et al. 1998. Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome. Am. J. Med. Genet. 75: 265-272.
6. Baldini, A. 2005. Dissecting contiguous gene defects: TBX1. Curr. Opin. Genet. Dev. 15: 279-284.
7. Bamford, R.N., Roessler, E., Burdine, R.D., Saplakoglu, U., dela Cruz, J., Splitt, M., Goodship, J.A., Towbin, J., Bowers, P., Ferrero, G.B., et al. 2000. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat. Genet. 26: 365-369.
8. Basson, C.T., Bachinsky, D.R., Lin, R.C., Levi, T., Elkins, J.A., Soults, J., Grayzel, D., Kroumpouzou, E., Traill, T.A., Leblanc-Straceski, J., et al. 1997. Mutations in human TBX5 (corrected) cause limb and cardiac malformation in Holt-Oram syndrome. Nat. Genet. 15: 30-35.
9. Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., et al. 2003. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
10. Benson, D.W., Wang, D.W., Dyment, M., Knilans, T.K., Fish, F.A., Strieper, M.J., Rhodes, T.H., and George, Jr., A.L. 2003. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J. Clin. Invest. 112: 1019-1028.
11. Benson, D.W., Silberbach, G.M., Kavanaugh-McHugh, A., Cottrill, C., Zhang, Y., Riggs, S., Smalls, O., Johnson, M.C., Watson, M.S., Seidman, J.G., et al. 1999. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J. Clin. Invest. 104: 1567-1573.
12. Black, B.L. 2007. Transcriptional pathways in second heart field development. Semin. Cell Dev. Biol. 18: 67-76.
13. Bondue, A., Lapouge, G., Paulissen, C., Semeraro, C., Iacovino, M., Kyba, M., and Blanpain, C. 2008. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 3: 69-84.
14. Buckingham, M., Meilhac, S., and Zaffran, S. 2005. Building the mammalian heart from two sources of myocardial cells. Nat. Rev. Genet. 6: 826-835.
15. Cai, C.L., Liang, X., Shi, Y., Chu, P.H., Pfaff, S.L., Chen, J., and Evans, S. 2003. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5: 877-889.
16. Cai, C.L., Martin, J.C., Sun, Y., Cui, L., Wang, L., Ouyang, K., Yang, L., Bu, L., Liang, X., Zhang, X., et al. 2008. A myocardial lineage derives from Tbx18 epicardial cells. Nature 454: 104-108.
17. Ching, Y.H., Ghosh, T.K., Cross, S.J., Packham, E.A., Honeyman, L., Loughna, S., Robinson, T.E., Dearlove, A.M., Ribas, G., Bonser, A.J., et al. 2005. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat. Genet. 37: 423-428.
18. Christoffels, V.M., Mommersteeg, M.T., Trowe, M.O., Prall, O.W., de Gier-de Vries, C., Soufan, A.T., Bussen, M., Schuster-Gossler, K., Harvey, R.P., Moorman, A.F., et al. 2006. Formation of the venous pole of the heart from an Nkx2-5-negative precursor population requires Tbx18. Circ. Res. 98: 1555-1563.
19. Cohen, E.D., Wang, Z., Lepore, J.J., Lu, M.M., Taketo, M.M., Epstein, D.J., and Morrisey, E.E. 2007. Wnt/β-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J. Clin. Invest. 117: 1794-1804.
20. Dasgupta, C., Martinez, A.M., Zuppan, C.W., Shah, M.M., Bailey, L.L., and Fletcher, W.H. 2001. Identification of connexin43 (α1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE). Mutat. Res. 479: 173-186.
21. Dodou, E., Verzi, M.P., Anderson, J.P., Xu, S.M., and Black, B.L. 2004. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 131: 3931-3942.
22. Ewart, A.K., Morris, C.A., Atkinson, D., Jin, W., Sternes, K., Spallone, P., Stock, A.D., Leppert, M., and Keating, M.T. 1993. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat. Genet. 5: 11-16.
23. Galli, D., Dominguez, J.N., Zaffran, S., Munk, A., Brown, N.A., and Buckingham, M.E. 2008. Atrial myocardium derives from the posterior region of the second heart field, which acquires left-right identity as Pitx2c is expressed. Development 135: 1157-1167.
24. Garg, V., Kathiriya, I.S., Barnes, R., Schluterman, M.K., King, I.N., Butler, C.A., Rothrock, C.R., Eapen, R.S., Hirayama-Yamada, K., Joo, K., et al. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447.
25. Garry, D.J. and Olson, E.N. 2006. A common progenitor at the heart of development. Cell 127: 1101-1104.
26. Gebbia, M., Ferrero, G.B., Pilia, G., Bassi, M.T., Aylsworth, A., Penman-Splitt, M., Bird, L.M., Bamforth, J.S., Burn, J., Schlessinger, D., et al. 1997. X-linked situs abnormalities result from mutations in ZIC3. Nat. Genet. 17: 305-308.
27. Goldmuntz, E., Geiger, E., and Benson, D.W. 2001. NKX2.5 mutations in patients with tetralogy of fallot. Circulation 104: 2565-2568.
28. Goldmuntz, E., Bamford, R., Karkera, J.D., dela Cruz, J., Roessler, E., and Muenke, M. 2002. CFC1 mutations in patients with transposition of the great arteries and doubleoutlet right ventricle. Am. J. Hum. Genet. 70: 776-780.
29. Gollob, M.H., Seger, J.J., Gollob, T.N., Tapscott, T., Gonzales, O., Bachinski, L., and Roberts, R. 2001a. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 104: 3030-3033.
30. Gollob, M.H., Green, M.S., Tang, A.S., Gollob, T., Karibe, A., Ali Hassan, A.S., Ahmad, F., Lozado, R., Shah, G., Fananapazir, L., et al. 2001b. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N. Engl. J. Med. 344: 1823-1831.
31. Goor, D.A. and Lillehei, C.W. 1975. Congenital malformations of the heart: Embryology, anatomy and operative considerations. Grune and Stratton, New York.
32. Gutierrez-Roelens, I., Sluysmans, T., Gewillig, M., Devriendt, K., and Vikkula, M. 2002. Progressive AV-block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2-5 gene. Hum. Mutat. 20: 75-76.
33. Hirayama-Yamada, K., Kamisago, M., Akimoto, K., Aotsuka, H., Nakamura, Y., Tomita, H., Furutani, M., Imamura, S., Takao, A., Nakazawa, M., et al. 2005. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am. J. Med. Genet. A 135: 47-52.
34. Hutson, M.R. and Kirby, M.L. 2007. Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Semin. Cell Dev. Biol. 18: 101-110.
35. Ichida, F., Tsubata, S., Bowles, K.R., Haneda, N., Uese, K., Miyawaki, T., Dreyer, W.J., Messina, J., Li, H., Bowles, N.E., et al. 2001. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 103: 1256-1263.
36. Ikeda, Y., Hiroi, Y., Hosoda, T., Utsunomiya, T., Matsuo, S., Ito, T., Inoue, J., Sumiyoshi, T., Takano, H., Nagai, R., et al. 2002. Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease. Circ. J. 66: 561-563.
37. Jerome, L.A. and Papaioannou, V.E. 2001. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 27: 286-291.
38. Kasahara, H. and Benson, D.W. 2004. Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies. Cardiovasc. Res. 64: 40-51.
39. Kasahara, H., Lee, B., Schott, J.J., Benson, D.W., Seidman, J.G., Seidman, C.E., and Izumo, S. 2000. Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J. Clin. Invest. 106: 299-308.
40. Kattman, S.J., Adler, E.D., and Keller, G.M. 2007. Specification of multipotential cardiovascular progenitor cells during embryonic stem cell differentiation and embryonic development. Trends Cardiovasc. Med. 17: 240-246.
41. + cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 11: 723-732.
42. Kelly, R.G. and Buckingham, M.E. 2002. The anterior heartforming field: Voyage to the arterial pole of the heart. Trends Genet. 18: 210-216.
43. Kelly, R.G., Brown, N.A., and Buckingham, M.E. 2001. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev. Cell 1: 435-440.
44. Kirk, E.P., Sunde, M., Costa, M.W., Rankin, S.A., Wolstein, O., Castro, M.L., Butler, T.L., Hyun, C., Guo, G., Otway, R., et al. 2007. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am. J. Hum. Genet. 81: 280-291.
45. Klaus, A., Saga, Y., Taketo, M.M., Tzahor, E., and Birchmeier, W. 2007. Distinct roles of Wnt/β-catenin and Bmp signaling during early cardiogenesis. Proc. Natl. Acad. Sci. 104: 18531-18536.
46. Kwon, C., Arnold, J., Hsiao, E.C., Taketo, M.M., Conklin, B.R., and Srivastava, D. 2007. Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors. Proc. Natl. Acad. Sci. 104: 10894-10899.
47. Lalani, S.R., Safiullah, A.M., Molinari, L.M., Fernbach, S.D., Martin, D.M., and Belmont, J.W. 2004. SEMA3E mutation in a patient with CHARGE syndrome. J. Med. Genet. 41: e94.
48. Laugwitz, K.L., Moretti, A., Caron, L., Nakano, A., and Chien, K.R. 2008. Islet1 cardiovascular progenitors: A single source for heart lineages? Development 135: 193-205.
49. + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-653.
50. Lepilina, A., Coon, A.N., Kikuchi, K., Holdway, J.E., Roberts, R.W., Burns, C.G., and Poss, K.D. 2006. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 127: 607-619.
51. Li, L., Krantz, I.D., Deng, Y., Genin, A., Banta, A.B., Collins, C.C., Qi, M., Trask, B.J., Kuo, W.L., Cochran, J., et al. 1997a. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 16: 243-251.
52. Li, Q.Y., Newbury-Ecob, R.A., Terrett, J.A., Wilson, D.I., Curtis, A.R., Yi, C.H., Gebuhr, T., Bullen, P.J., Robson, S.C., Strachan, T., et al. 1997b. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat. Genet. 15: 21-29.
53. Li, Y., Bollag, G., Clark, R., Stevens, J., Conroy, L., Fults, D., Ward, K., Friedman, E., Samowitz, W., Robertson, M., et al. 1992. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69: 275-281.
54. Lin, A.E., Birch, P.H., Korf, B.R., Tenconi, R., Niimura, M., Poyhonen, M., Armfield Uhas, K., Sigorini, M., Virdis, R., Romano, C., et al. 2000. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am. J. Med. Genet. 95: 108-117.
55. Lin, L., Cui, L., Zhou, W., Dufort, D., Zhang, X., Cai, C.L., Bu, L., Yang, L., Martin, J., Kemler, R., et al. 2007. β-Catenin directly regulates Islet1 expression in cardiovascular progenitors and is required for multiple aspects of cardiogenesis. Proc. Natl. Acad. Sci. 104: 9313-9318.
56. Lindsay, E.A., Vitelli, F., Su, H., Morishima, M., Huynh, T., Pramparo, T., Jurecic, V., Ogunrinu, G., Sutherland, H.F., Scambler, P.J., et al. 2001. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410: 97-101.
57. Lindsley, R.C., Gill, J.G., Murphy, T.L., Langer, E.M., Cai, M., Mashayekhi, M., Wang, W., Niwa, N., Nerbonne, J.M., Kyba, M., et al. 2008. Mesp1 coordinately regulates cardiovascular fate restriction and epithelial- mesenchymal transition in differentiating ESCs. Cell Stem Cell 3: 55-68.
58. Majesky, M.W. 2007. Developmental basis of vascular smooth muscle diversity. Arterioscler. Thromb. Vasc. Biol. 27: 1248-1258.
59. Martin-Puig, S., Wang, Z., and Chien, K.R. 2008. Lives of a heart cell: Tracing the origins of cardiac progenitors. Cell Stem Cell 2: 320-331.
60. Marvin, M.J., Di Rocco, G., Gardiner, A., Bush, S.M., and Lassar, A.B. 2001. Inhibition ofWnt activity induces heart formation from posterior mesoderm. Genes Dev. 15: 316-327.
61. Maslen, C.L., Babcock, D., Robinson, S.W., Bean, L.J., Dooley, K.J., Willour, V.L., and Sherman, S.L. 2006. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am. J. Med. Genet. A 140: 2501-2505.
62. McDaniell, R., Warthen, D.M., Sanchez-Lara, P.A., Pai, A., Krantz, I.D., Piccoli, D.A., and Spinner, N.B. 2006. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 79: 169-173.
63. McElhinney, D.B., Geiger, E., Blinder, J., Benson, D.W., and Goldmuntz, E. 2003. NKX2.5 mutations in patients with congenital heart disease. J. Am. Coll. Cardiol. 42: 1650-1655.
64. Meilhac, S.M., Esner, M., Kelly, R.G., Nicolas, J.F., and Buckingham, M.E. 2004. The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev. Cell 6: 685-698.
65. Merscher, S., Funke, B., Epstein, J.A., Heyer, J., Puech, A., Lu, M.M., Xavier, R.J., Demay, M.B., Russell, R.G., Factor, S., et al. 2001. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104: 619-629.
66. Mikawa, T. and Gourdie, R.G. 1996. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev. Biol. 221-232.
67. Mjaatvedt, C.H., Nakaoka, T., Moreno-Rodriguez, R., Norris, R.A., Kern, M.J., Eisenberg, C.A., Turner, D., and Markwald, R.R. 2001. The outflow tract of the heart is recruited from a novel heart-forming field. Dev. Biol. 238: 97-109.
68. Moorman, A.F., Christoffels, V.M., Anderson, R.H., and van den Hoff, M.J. 2007. The heart-forming fields: One or multiple? Philos. Trans. R. Soc. Lond. B Biol. Sci. 362: 1257-1265.
69. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127: 1151-1165.
70. Muncke, N., Jung, C., Rudiger, H., Ulmer, H., Roeth, R., Hubert, A., Goldmuntz, E., Driscoll, D., Goodship, J., Schon, K., et al. 2003. Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation 108: 2843-2850.
71. Murry, C.E., Field, L.J., and Menasche, P. 2005. Cell-based cardiac repair: Reflections at the 10-year point. Circulation 112: 3174-3183.
72. Naito, A.T., Shiojima, I., Akazawa, H., Hidaka, K., Morisaki, T., Kikuchi, A., and Komuro, I. 2006. Developmental stage-specific biphasic roles of Wnt/β-catenin signaling in cardiomyogenesis and hematopoiesis. Proc. Natl. Acad. Sci. 103: 19812-19817.
73. Niihori, T., Aoki, Y., Narumi, Y., Neri, G., Cave, H., Verloes, A., Okamoto, N., Hennekam, R.C., Gillessen-Kaesbach, G., Wieczorek, D., et al. 2006. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat. Genet. 38: 294-296.
74. Oda, T., Elkahloun, A.G., Pike, B.L., Okajima, K., Krantz, I.D., Genin, A., Piccoli, D.A.,Meltzer, P.S., Spinner, N.B., Collins, F.S., et al. 1997. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet. 16: 235-242.
75. Oh, H., Bradfute, S.B., Gallardo, T.D., Nakamura, T., Gaussin, V., Mishina, Y., Pocius, J., Michael, L.H., Behringer, R.R., Garry, D.J., et al. 2003. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. 100: 12313-12318.
76. Olson, E.N. 2006. Gene regulatory networks in the evolution and development of the heart. Science 313: 1922-1927.
77. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D.M., et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
78. Pashmforoush, M., Lu, J.T., Chen, H., Amand, T.S., Kondo, R., Pradervand, S., Evans, S.M., Clark, B., Feramisco, J.R., Giles, W., et al. 2004. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117: 373-386.
79. Pehlivan, T., Pober, B.R., Brueckner, M., Garrett, S., Slaugh, R., Van Rheeden, R., Wilson, D.B., Watson, M.S., and Hing, A.V. 1999. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am. J. Med. Genet. 83: 201-206.
80. Pizzuti, A., Sarkozy, A., Newton, A.L., Conti, E., Flex, E., Digilio, M.C., Amati, F., Gianni, D., Tandoi, C., Marino, B., et al. 2003. Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot. Hum. Mutat. 22: 372-377.
81. Prall, O.W., Menon, M.K., Solloway, M.J., Watanabe, Y., Zaffran, S., Bajolle, F., Biben, C., McBride, J.J., Robertson, B.R., Chaulet, H., et al. 2007. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 128: 947-959.
82. + cardiovascular progenitors are controlled by a Wnt/β-catenin pathway. Cell Stem Cell 1: 165-179.
83. Robinson, S.W., Morris, C.D., Goldmuntz, E., Reller, M.D., Jones, M.A., Steiner, R.D., and Maslen, C.L. 2003. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am. J. Hum. Genet. 72: 1047-1052.
84. Rodriguez-Viciana, P., Tetsu, O., Tidyman, W.E., Estep, A.L., Conger, B.A., Cruz, M.S., McCormick, F., and Rauen, K.A. 2006. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311: 1287-1290.
85. Rubart,M. and Field, L.J. 2008. Stem cell differentiation: Cardiac repair. Cells Tissues Organs 188: 202-211.
86. Sadr, I.M., Tan, P.E., Kieran, M.W., and Jenkins, K.J. 2000. Mechanism of pulmonary vein stenosis in infants with normally connected veins. Am. J. Cardiol. 86: 577-579.
87. Satoda, M., Zhao, F., Diaz, G.A., Burn, J., Goodship, J., Davidson, H.R., Pierpont, M.E., and Gelb, B.D. 2000. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat. Genet. 25: 42-46.
88. Schneider, V.A. and Mercola, M. 2001. Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev. 15: 304-315.
89. Schott, J.J., Benson, D.W., Basson, C.T., Pease, W., Silberbach, G.M., Moak, J.P., Maron, B.J., Seidman, C.E., and Seidman, J.G. 1998. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281: 108-111.
90. Schubbert, S., Zenker, M., Rowe, S.L., Boll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.E., et al. 2006. Germline KRAS mutations cause Noonan syndrome. Nat. Genet. 38: 331-336.
91. Snarr, B.S., Wirrig, E.E., Phelps, A.L., Trusk, T.C., and Wessels, A. 2007a. A spatiotemporal evaluation of the contribution of the dorsal mesenchymal protrusion to cardiac development. Dev. Dyn. 236: 1287-1294.
92. Snarr, B.S.,O'Neal, J.L., Chintalapudi,M.R.,Wirrig, E.E., Phelps, A.L., Kubalak, S.W., andWessels, A. 2007b. Isl1 expression at the venous pole identifies a novel role for the second heart field in cardiac development. Circ. Res. 101: 971-974.
93. Snider, P., Olaopa, M., Firulli, A.B., and Conway, S.J. 2007. Cardiovascular development and the colonizing cardiac neural crest lineage. ScientificWorldJournal 7: 1090-1113.
94. Srivastava, D. 2006. Making or breaking the heart: From lineage determination to morphogenesis. Cell 126: 1037-1048.
95. Srivastava, D. and Ivey, K.N. 2006. Potential of stem-cell-based therapies for heart disease. Nature 441: 1097-1099.
96. Stalmans, I., Lambrechts, D., De Smet, F., Jansen, S., Wang, J., Maity, S., Kneer, P., von der Ohe, M., Swillen, A., Maes, C., et al. 2003. VEGF: A modifier of the del22q11 (DiGeorge) syndrome? Nat. Med. 9: 173-182.
97. Stoller, J.Z. and Epstein, J.A. 2005. Cardiac neural crest. Semin. Cell Dev. Biol. 16: 704-715.
98. Sun, Y., Liang, X., Najafi, N., Cass, M., Lin, L., Cai, C.L., Chen, J., and Evans, S.M. 2007. Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells. Dev. Biol. 304: 286-296.
99. Tartaglia, M., Mehler, E.L., Goldberg, R., Zampino, G., Brunner, H.G., Kremer, H., van der Burgt, I., Crosby, A.H., Ion, A., Jeffery, S., et al. 2001. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29: 465-468.
100. Topouzis, S. and Majesky, M.W. 1996. Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-β. Dev. Biol. 178: 430-445.
101. Tzahor, E. 2007. Wnt/β-catenin signaling and cardiogenesis: Timing does matter. Dev. Cell 13: 10-13.
102. Tzahor, E. and Lassar, A.B. 2001. Wnt signals from the neural tube block ectopic cardiogenesis. Genes Dev. 15: 255-260.
103. Ueno, S., Weidinger, G., Osugi, T., Kohn, A.D., Golob, J.L., Pabon, L., Reinecke, H., Moon, R.T., and Murry, C.E. 2007. Biphasic role for Wnt/β-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc. Natl. Acad. Sci. 104: 9685-9690.
104. Vissers, L.E., van Ravenswaaij, C.M., Admiraal, R., Hurst, J.A., de Vries, B.B., Janssen, I.M., van der Vliet, W.A., Huys, E.H., de Jong, P.J., Hamel, B.C., et al. 2004. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat. Genet. 36: 955-957.
105. Waldo, K.L. and Kirby,M.L. 1993. Cardiac neural crest contribution to the pulmonary artery and sixth aortic arch artery complex in chick embryos aged 6 to 18 days. Anat. Rec. 237: 385-399.
106. Waldo, K.L., Hutson, M.R., Stadt, H.A., Zdanowicz, M., Zdanowicz, J., and Kirby, M.L. 2005a. Cardiac neural crest is necessary for normal addition of the myocardium to the arterial pole from the secondary heart field. Dev. Biol. 281: 66-77.
107. Waldo, K.L., Kumiski, D.H., Wallis, K.T., Stadt, H.A., Hutson, M.R., Platt, D.H., and Kirby, M.L. 2001. Conotruncal myocardium arises from a secondary heart field. Development 128: 3179-3188.
108. Waldo, K.L., Hutson, M.R., Ward, C.C., Zdanowicz, M., Stadt, H.A., Kumiski, D., Abu-Issa, R., and Kirby, M.L. 2005b. Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart. Dev. Biol. 281: 78-90.
109. Watanabe, Y., Benson, D.W., Yano, S., Akagi, T., Yoshino, M., and Murray, J.C. 2002. Two novel frameshift mutations in NKX2.5 result in novel features including visceral inversus and sinus venosus type ASD. J. Med. Genet. 39: 807-811.
110. Wu, S.M. 2008. Mesp1 at the heart of mesoderm lineage specification. Cell Stem Cell 3: 1-2.
111. Wu, S.M., Fujiwara, Y., Cibulsky, S.M., Clapham, D.E., Lien, C.L., Schultheiss, T.M., and Orkin, S.H. 2006. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127: 1137-1150.
112. Yagi, H., Furutani, Y., Hamada, H., Sasaki, T., Asakawa, S., Minoshima, S., Ichida, F., Joo, K., Kimura, M., Imamura, S., et al. 2003. Role of TBX1 in human del22q11.2 syndrome. Lancet 362: 1366-1373.
113. + embryonic-stem-cellderived population. Nature 453: 524-528.
114. Yelbuz, T.M., Waldo, K.L., Kumiski, D.H., Stadt, H.A., Wolfe, R.R., Leatherbury, L., and Kirby, M.L. 2002. Shortened outflow tract leads to altered cardiac looping after neural crest ablation. Circulation 106: 504-510.
115. Zatyka, M., Priestley, M., Ladusans, E.J., Fryer, A.E., Mason, J., Latif, F., and Maher, E.R. 2005. Analysis of CRELD1 as a candidate 3p25 atrioventicular septal defect locus (AVSD2). Clin. Genet. 67: 526-528.
116. Zhao, F.,Weismann, C.G., Satoda,M., Pierpont,M.E., Sweeney, E., Thompson, E.M., and Gelb, B.D. 2001. Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. Am. J. Hum. Genet. 69: 695-703.
117. Zhou, B., Ma, Q., Rajagopal, S., Wu, S.M., Domian, I., Rivera-Feliciano, J., Jiang, D., von Gise, A., Ikeda, S., Chien, K.R., et al. 2008. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454: 109-113.